breakthroughsautism
Big Think hosted a panel discussion highlighting cutting-edge autism research as part of our Breakthroughs series, made possible by Pfizer.
This conversation features back-and-forth exchanges between top luminaries in the field, including
Many kids are vaccinated at age two, the same age at which autism is often first noticed. But the “evidence” that one causes the other doesn’t wash.
Autism science is making great strides, but the search for a cure remains “a marathon, not a sprint.” The challenge is not one disorder but many.
▸
2 min
—
with
New drugs for patients may be on the horizon, but “early, intense” behavioral treatment remains “the very best intervention for autism.”
▸
2 min
—
with
Four out of five autism sufferers are male. Is something in men’s genes—or brain structure—causing the gap?
▸
4 min
—
with
Autism isn’t on the rise: it’s just getting defined better, and diagnosed more.
▸
4 min
—
with
Autism sufferers unquestionably have feelings. It’s processing those feelings—and reading them in others—that they struggle with.
▸
5 min
—
with
Many kids are vaccinated at age two, the same age at which autism is often first noticed. But the “evidence” that one causes the other doesn’t wash.
▸
6 min
—
with
The symptoms of autism are better understood than its causes; psychiatrists classify the disorder as having two major components: impaired social cognition and a tendency toward narrow interests and repetitive […]
▸
5 min
—
with
There is not a single gene that triggers autism, but more likely dozens of genes that enhance the risk of autism.
▸
5 min
—
with
Big Think presents a conversation between top experts highlighting cutting-edge autism research.
▸
34 min
—
with